27
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment Jackie Tran, MD University of Medicine and Dentistry of New Jersey, USA HTAi 9 th Annual Meeting, Bilbao Integrated Care for a Patient Centered System 25 June, 2012

Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Embed Size (px)

DESCRIPTION

Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment Jackie Tran, MD University of Medicine and Dentistry of New Jersey, USA HTAi 9th Annual Meeting, Bilbao Integrated Care for a Patient Centered System 25 June, 2012

Citation preview

Page 1: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Transitional Care for PediatricPatients with Neuromuscular

Diseases: A Health Technology Assessment

Jackie Tran, MDUniversity of Medicine and Dentistry of New

Jersey, USA

HTAi 9th Annual Meeting, BilbaoIntegrated Care for a Patient Centered System

25 June, 2012

Page 2: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Outline

Background Transitional Care Overview Neuromuscular Diseases Overview

Objectives Methods Results

Barriers Recommendations

Conclusions

Page 3: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Transitional Care OverviewBackground

Page 4: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Unique Adult Needs

Physical maturation Size Endocrine management Deformities

Sexual maturation Menstruation Fertility Pregnancy

Psychosocial maturation Identity Experimentation Independence Family/Friends

Intellectual maturation Education Vocation

Page 5: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Reality: Unmet Needs

Increase hospitalization, particularly of ages 18-21

© Pediatrics. 2011 Jul;128(1):5-13. Epub 2011 Jun 27.Adults with chronic health conditions originating in childhood: inpatient experience in children's hospitals.

Page 6: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Reality: Unmet Needs

Non-adherence to medications over a lifetime in renal transplant patients

Decrease clinic attendance and an average of 1.47 health provider changes in diabetes type 1 patients

Decrease mobility in spina bifida patients during transitional years

Increase long-term morbidity and mortality in cystic fibrosis patients

Page 7: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Neuromuscular Diseases Overview

Background

Page 8: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Selected Neuromuscular Diseases

of ChildhoodCongenital

myopathies dystrophic (e.g., Duchenne) myotonic congenital

spinal muscle atrophy congenital myasthenia hereditary motor

sensory neuopathy Friedreich ataxia

Acquired

Guillain-Barré syndrome

myasthenia gravis polymyositis toxic myopathy

Page 9: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Epidemiology

Worldwide prevalence of disabling, inherited neuromuscular diseases: 1 in 3,500

Increased survival rate to adulthoodSome Survival Statistics in the Literature

60% of males born with Duchenne between 1983 – 1987 survived past age 24

More than 33% of Charcot-Marie-Tooth Type 2 patients live past the third decade of life

A patient with Type 2 SMA have survival rate of 68.5% at age 25

Page 10: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Unique Characteristics

Low recognition Apparent functional deficits Infamous progressive/regressive

courses Media portrayal Multi-organ systems involvement Large team investment

Page 11: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Equally Poor Transitional Care

A glaring 60% of 850 people living with muscle disease rate transition from child to adult services as “poor” or

“very poor”

Muscular Dystrophy Campaign 2008 survey

Page 12: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Finding Transitional Solutions

Objectives & Methods

Page 13: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Objectives

Identify systematic and unique barriers to a successful transition of care for adolescents with neuromuscular diseases (NMDs).

Recommend comprehensive strategies to improve the experience for patients, family members, and health providers alike.

Page 14: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Methods

Systematic literature review of publications between January 2000 and December 2011

Informal survey of local clinicians’ opinions

Page 15: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Only the beginning…Results

Page 16: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

General Observations

Notable publication increase on transitional care over the past 5 years

Emphasis on the following diagnoses: diabetes, cancer, renal transplant, inflammatory bowel

dz cerebral palsy and spina bifida

Most prolific countries: USA, Canada and UK Honorable mentions: Australia, France, Japan,

Switzerland

Page 17: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

All Transitional Care Publications

NMD-Relevant Publications

Number of

Publications

60+ 14

Population description

• generic: “chronic illnesses” & “special health care needs” & “congenital disabilities” & “developmental

disabilities”

• multiple diagnoses-specific publications

• inter-mix with spina bifida & cerebral palsy &

“chronic neurological disorders”

• Duchenne dystrophy

Page 18: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

All Transitional Care Publications

NMD-Relevant Publications

Publication

Content

• highlight need for transitional care• clinician & patient survey/commentaries

• anecdote / case reports

• single-institution experience

• general critiques of current transition

processes & models

• review of medical topics on transitional ages

Outcome measure

s

• subjective reports of wellness & satisfaction

• individual programs: admissions & biomarkers

(retrospective & limited to 1 year after transition)

• health expenditure at transitional age as a secondary outcome

Page 19: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Models of Transitional Care

Diagnosis-focused (most common)

pediatric and adult provider collaboration

Medical home-based (least common)

primary care practitioner as coordinator

Adolescent-focused physical, physiological, social issues focused

Transition-based outreach representatives from one facility

Page 20: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

General Barriers

Afterthought process Provider availability (absolute & time)

Coordinator responsibility Decision-making capacity Advisors resourcefulness Insurance coverage Transportation / Architectural Medical records Ventilator, dialysis

Page 21: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Emotional Barriers

Patient & Family neglect

abandonment

Adult team burden

unfamiliarity

Peds team attachment

over-confidence

FearAnxietyDistrust

Uncertainty

Page 22: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Unique Barriers &

Opportunities

Assistive technology Malpractice insurance

Insurance / resources for the very ill Association with spina bifida and/or cerebral

palsy

Even more limited provider availability Institutionalized patients Aging care providers Uncertain future

Barriers

Opportunities

Page 23: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Recommendations

Early notification Individualized plan

flexible but definitive date of transition assess cognitive/emotional and functional

status gradual promote of independence

Comprehensive approach patient’s and family members’ input interdisciplinary team

Page 24: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Recommendations

Coordinator designation Patient education

self care and disease process healthcare system navigation

Long-term planning vocation and education living situation

Resources availability

Page 25: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Advanced Topics

Program sustainability Provider training Transition to palliative care Socioeconomic status effects

Page 26: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Conclusions

All children with neuromuscular diseases need a transition plan before entering adulthood

Successful transition requires coordination of services across all providers

Especially for individuals affected by NMDs, the transition plan should incorporate patient’s and family’s long-term goals

Page 27: Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment

Primary References

Abbott, D. Transition to adulthood for young men with Duchenne Muscular Dystrophy. International Journal of Integrated Care, 31 December 2009 - ISSN 1568-415

Centers for Disease Control and Prevention (CDC). Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. MMWR Morb Mortal Wkly Rep. 2009 Oct 16;58(40):1119-22.

Strehle EM. Long-term management of children with neuromuscular disorders. J Pediatr (Rio J). 2009 Sep-Oct;85(5):379-84. Tiffreau V, et al. Ann Readapt Med Phys. 2006 Dec;49(9):652-8. Epub 2006 Jun 27. [Transition in health care from youth to

adulthood for disabled people]. Ouyang L, et al. Health care utilization and expenditures for childrenand young adults with muscular dystrophy in a privately insured

population. J Child Neurol. 2008 Aug;23(8):883-8. Epub 2008 Apr 10. Manzur AY, Muntoni F. Diagnosis and new treatments in musculardystrophies. J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):706-

14. Hill ME, Phillips MF. Service provision for adults with long-term disability: a review of services for adults with chronic

neuromuscular conditions in the United Kingdom. Neuromuscul Disord. 2006 Feb;16(2):107-12. Epub 2006 Jan 19. Nomura Y. [Care continuity for patients with myasthenia gravis during transition from childhood to adulthood]. Nihon Rinsho. 2010

Jan;68(1):39-44. Yoshioka M, et al. [Care continuity for patients with myopathy during transition of childhood to adulthood]. Nihon Rinsho. 2010

Jan;68(1):53-6. Minicozzi A. Transition to adult care: another view. Pediatr Nurs. 2000 Jul-Aug;26(4):411-2. Katz JD, et al. Parents' perception of self-advocacy of children with myositis: an anonymous online survey. Pediatr Rheumatol Online

J. 2011 Jun 7;9(1):10. Goodman DM, et al. Adults with chronic health conditions originating in childhood: inpatient experience in children's hospitals.

Pediatrics. 2011 Jul;128(1):5-13. Epub 2011 Jun 27. Rearick E. Enhancing success in transition service coordinators: use of transformational leadership. Prof Case Manag. 2007 Sep-

Oct;12(5):283-7. Parker AE, et al. Analysis of an adult Duchenne muscular dystrophy population. QJM. 2005 Oct;98(10):729-36. Epub 2005 Aug 31.